Showing results (1401-1410 of 1,689) with videos related to
Sort By:
Pageof 169
Nature Genetics|October 1, 2021
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variantMariana G López, Álvaro Chiner-Oms, Darío García de Viedma, et al.Allergy|October 5, 2010
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paperJean Bousquet, H J Schünemann, T Zuberbier, et al.International Archives of Allergy and Immunology|March 3, 2012
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper, J Bousquet, J M Anto, et al.The Journal of Frailty & Aging|November 25, 2016
MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy AgeingJ Bousquet, R Bourret, T Camuzat, et al.The Journal of Allergy and Clinical Immunology|October 9, 2012
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needsJ Bousquet, H J Schünemann, B Samolinski, et al.Allergy|July 7, 2015
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementationJ Bousquet, H J Schunemann, J Fonseca, et al.The Journal of Nutrition, Health & Aging|December 22, 2016
Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHAJ Bousquet, M Bewick, A Cano, et al.Allergy|June 9, 2020
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practiceJean Bousquet, Josep M Anto, Claus Bachert, et al.Clinical and Translational Allergy|February 28, 2017
Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)J Bousquet, J Farrell, G Crooks, et al.Clinical and Translational Allergy|August 2, 2016
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)J Bousquet, J Farrell, G Crooks, et al.Pageof 169